The Experts below are selected from a list of 111 Experts worldwide ranked by ideXlab platform

Fiona C. Denison - One of the best experts on this subject based on the ideXlab platform.

  • PA.03 Outcomes of Outpatient Cervical Ripening with 1mg Dinoprostone Gel in Primiparous Singleton Pregnancy: A Cohort Study
    Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Chris Kissack, Jane E Norman, Imogen B. J. Smith, R A M Taylor, Kc Dundas, Fiona C. Denison
    Abstract:

    Aim To determine the safety and clinical effectiveness of outpatient cervical ripening with Dinoprostone 1 mg. Methods Retrospective cohort study of women with singleton pregnancies having induction of labour (IOL) for Postmaturity at the Royal Infirmary of Edinburgh between January 2007 and June 2010 (n = 1,536). Women were offered outpatient cervical ripening with 1mg Dinoprostone gel if they were primiparous; had uncomplicated singleton pregnancies; and the primary indication for IOL was Postmaturity (term +10 -14 days). Findings 907 (59.1%) women were eligible for outpatient cervical ripening and 85 (5.5%) women had inpatient cervical ripening only because of preference or social indication (comparison group; n = 85). 597/907 (65.8%) in outpatient cervical ripening group completed the protocol, with median number of hours at home of 11.76 h (range 0–24.82 h). No babies were born at home. Mode of delivery, requirement for further Dinoprostone, failed IOL and neonatal unit admission rates were similar in outpatient and inpatient cervical ripening groups. The mean time to delivery was significantly longer in the outpatient group (35.45 [95% confidence interval 34.36–36.53] in outpatient group versus 22.5 [95% confidence interval 21.06–23.95] in the inpatient group p Conclusion Clinical outcomes for outpatient cervical ripening are similar to those of inpatient ripening. Surprisingly, outpatient ripening did not decrease the number of hours women spend in hospital.

  • Home Cervical Ripening With Dinoprostone Gel in Nulliparous Women with Singleton Pregnancies
    Obstetrics & Gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Kirsty Dundas, Chris Kissack, Jane E Norman, Rebecca E. Taylor, Imogen B. J. Smith, Fiona C. Denison
    Abstract:

    OBJECTIVE:To evaluate whether home cervical ripening is safe and results in shorter hospital stay.METHODS:This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered hom

Sarah J Stock - One of the best experts on this subject based on the ideXlab platform.

  • PA.03 Outcomes of Outpatient Cervical Ripening with 1mg Dinoprostone Gel in Primiparous Singleton Pregnancy: A Cohort Study
    Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Chris Kissack, Jane E Norman, Imogen B. J. Smith, R A M Taylor, Kc Dundas, Fiona C. Denison
    Abstract:

    Aim To determine the safety and clinical effectiveness of outpatient cervical ripening with Dinoprostone 1 mg. Methods Retrospective cohort study of women with singleton pregnancies having induction of labour (IOL) for Postmaturity at the Royal Infirmary of Edinburgh between January 2007 and June 2010 (n = 1,536). Women were offered outpatient cervical ripening with 1mg Dinoprostone gel if they were primiparous; had uncomplicated singleton pregnancies; and the primary indication for IOL was Postmaturity (term +10 -14 days). Findings 907 (59.1%) women were eligible for outpatient cervical ripening and 85 (5.5%) women had inpatient cervical ripening only because of preference or social indication (comparison group; n = 85). 597/907 (65.8%) in outpatient cervical ripening group completed the protocol, with median number of hours at home of 11.76 h (range 0–24.82 h). No babies were born at home. Mode of delivery, requirement for further Dinoprostone, failed IOL and neonatal unit admission rates were similar in outpatient and inpatient cervical ripening groups. The mean time to delivery was significantly longer in the outpatient group (35.45 [95% confidence interval 34.36–36.53] in outpatient group versus 22.5 [95% confidence interval 21.06–23.95] in the inpatient group p Conclusion Clinical outcomes for outpatient cervical ripening are similar to those of inpatient ripening. Surprisingly, outpatient ripening did not decrease the number of hours women spend in hospital.

  • Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies.
    Obstetrics and gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Taylor, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Imogen Smith, Kirsty Dundas, Chris Kissack, Jane E Norman, Fiona Denison
    Abstract:

    To evaluate whether home cervical ripening is safe and results in shorter hospital stay. This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered home cervical ripening with 1 mg dinoprostone gel if they were nulliparous, had uncomplicated singleton pregnancies, and the indication for induction was Postmaturity. Nine hundred seven of 1,536 (59.1%) nulliparous women having induction of labor for Postmaturity were eligible for home cervical ripening. The median number of hours at home was 11.76 hours (range 0-24.82 hours). There were no cases of birth outside of the hospital, uterine rupture, or significant neonatal morbidity or neonatal death related to home cervical ripening. Eighty-five (5.5%) women who underwent hospital cervical ripening because of maternal preference or social issues formed a hospital cervical ripening comparison group. There was no significant difference in the total number of hours before delivery spent in the hospital between the two groups (26.25; 95% confidence interval [CI] 25.27-27.23 in home cervical ripening group compared with 24.28; 95% CI 22.5-26.0 in the hospital group; P=.26). Clinical outcomes are comparable in nulliparous women who receive a single dose of dinoprostone gel for home cervical ripening compared with those who undergo hospital cervical ripening. However, preadmission home cervical ripening with 1 mg dinoprostone does not decrease the number of hours women spend in the hospital. II.

  • Home Cervical Ripening With Dinoprostone Gel in Nulliparous Women with Singleton Pregnancies
    Obstetrics & Gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Kirsty Dundas, Chris Kissack, Jane E Norman, Rebecca E. Taylor, Imogen B. J. Smith, Fiona C. Denison
    Abstract:

    OBJECTIVE:To evaluate whether home cervical ripening is safe and results in shorter hospital stay.METHODS:This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered hom

Rebecca Mairs - One of the best experts on this subject based on the ideXlab platform.

  • PA.03 Outcomes of Outpatient Cervical Ripening with 1mg Dinoprostone Gel in Primiparous Singleton Pregnancy: A Cohort Study
    Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Chris Kissack, Jane E Norman, Imogen B. J. Smith, R A M Taylor, Kc Dundas, Fiona C. Denison
    Abstract:

    Aim To determine the safety and clinical effectiveness of outpatient cervical ripening with Dinoprostone 1 mg. Methods Retrospective cohort study of women with singleton pregnancies having induction of labour (IOL) for Postmaturity at the Royal Infirmary of Edinburgh between January 2007 and June 2010 (n = 1,536). Women were offered outpatient cervical ripening with 1mg Dinoprostone gel if they were primiparous; had uncomplicated singleton pregnancies; and the primary indication for IOL was Postmaturity (term +10 -14 days). Findings 907 (59.1%) women were eligible for outpatient cervical ripening and 85 (5.5%) women had inpatient cervical ripening only because of preference or social indication (comparison group; n = 85). 597/907 (65.8%) in outpatient cervical ripening group completed the protocol, with median number of hours at home of 11.76 h (range 0–24.82 h). No babies were born at home. Mode of delivery, requirement for further Dinoprostone, failed IOL and neonatal unit admission rates were similar in outpatient and inpatient cervical ripening groups. The mean time to delivery was significantly longer in the outpatient group (35.45 [95% confidence interval 34.36–36.53] in outpatient group versus 22.5 [95% confidence interval 21.06–23.95] in the inpatient group p Conclusion Clinical outcomes for outpatient cervical ripening are similar to those of inpatient ripening. Surprisingly, outpatient ripening did not decrease the number of hours women spend in hospital.

  • Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies.
    Obstetrics and gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Taylor, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Imogen Smith, Kirsty Dundas, Chris Kissack, Jane E Norman, Fiona Denison
    Abstract:

    To evaluate whether home cervical ripening is safe and results in shorter hospital stay. This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered home cervical ripening with 1 mg dinoprostone gel if they were nulliparous, had uncomplicated singleton pregnancies, and the indication for induction was Postmaturity. Nine hundred seven of 1,536 (59.1%) nulliparous women having induction of labor for Postmaturity were eligible for home cervical ripening. The median number of hours at home was 11.76 hours (range 0-24.82 hours). There were no cases of birth outside of the hospital, uterine rupture, or significant neonatal morbidity or neonatal death related to home cervical ripening. Eighty-five (5.5%) women who underwent hospital cervical ripening because of maternal preference or social issues formed a hospital cervical ripening comparison group. There was no significant difference in the total number of hours before delivery spent in the hospital between the two groups (26.25; 95% confidence interval [CI] 25.27-27.23 in home cervical ripening group compared with 24.28; 95% CI 22.5-26.0 in the hospital group; P=.26). Clinical outcomes are comparable in nulliparous women who receive a single dose of dinoprostone gel for home cervical ripening compared with those who undergo hospital cervical ripening. However, preadmission home cervical ripening with 1 mg dinoprostone does not decrease the number of hours women spend in the hospital. II.

  • Home Cervical Ripening With Dinoprostone Gel in Nulliparous Women with Singleton Pregnancies
    Obstetrics & Gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Kirsty Dundas, Chris Kissack, Jane E Norman, Rebecca E. Taylor, Imogen B. J. Smith, Fiona C. Denison
    Abstract:

    OBJECTIVE:To evaluate whether home cervical ripening is safe and results in shorter hospital stay.METHODS:This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered hom

Abdulhamid Azaghdani - One of the best experts on this subject based on the ideXlab platform.

  • PA.03 Outcomes of Outpatient Cervical Ripening with 1mg Dinoprostone Gel in Primiparous Singleton Pregnancy: A Cohort Study
    Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Chris Kissack, Jane E Norman, Imogen B. J. Smith, R A M Taylor, Kc Dundas, Fiona C. Denison
    Abstract:

    Aim To determine the safety and clinical effectiveness of outpatient cervical ripening with Dinoprostone 1 mg. Methods Retrospective cohort study of women with singleton pregnancies having induction of labour (IOL) for Postmaturity at the Royal Infirmary of Edinburgh between January 2007 and June 2010 (n = 1,536). Women were offered outpatient cervical ripening with 1mg Dinoprostone gel if they were primiparous; had uncomplicated singleton pregnancies; and the primary indication for IOL was Postmaturity (term +10 -14 days). Findings 907 (59.1%) women were eligible for outpatient cervical ripening and 85 (5.5%) women had inpatient cervical ripening only because of preference or social indication (comparison group; n = 85). 597/907 (65.8%) in outpatient cervical ripening group completed the protocol, with median number of hours at home of 11.76 h (range 0–24.82 h). No babies were born at home. Mode of delivery, requirement for further Dinoprostone, failed IOL and neonatal unit admission rates were similar in outpatient and inpatient cervical ripening groups. The mean time to delivery was significantly longer in the outpatient group (35.45 [95% confidence interval 34.36–36.53] in outpatient group versus 22.5 [95% confidence interval 21.06–23.95] in the inpatient group p Conclusion Clinical outcomes for outpatient cervical ripening are similar to those of inpatient ripening. Surprisingly, outpatient ripening did not decrease the number of hours women spend in hospital.

  • Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies.
    Obstetrics and gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Taylor, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Imogen Smith, Kirsty Dundas, Chris Kissack, Jane E Norman, Fiona Denison
    Abstract:

    To evaluate whether home cervical ripening is safe and results in shorter hospital stay. This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered home cervical ripening with 1 mg dinoprostone gel if they were nulliparous, had uncomplicated singleton pregnancies, and the indication for induction was Postmaturity. Nine hundred seven of 1,536 (59.1%) nulliparous women having induction of labor for Postmaturity were eligible for home cervical ripening. The median number of hours at home was 11.76 hours (range 0-24.82 hours). There were no cases of birth outside of the hospital, uterine rupture, or significant neonatal morbidity or neonatal death related to home cervical ripening. Eighty-five (5.5%) women who underwent hospital cervical ripening because of maternal preference or social issues formed a hospital cervical ripening comparison group. There was no significant difference in the total number of hours before delivery spent in the hospital between the two groups (26.25; 95% confidence interval [CI] 25.27-27.23 in home cervical ripening group compared with 24.28; 95% CI 22.5-26.0 in the hospital group; P=.26). Clinical outcomes are comparable in nulliparous women who receive a single dose of dinoprostone gel for home cervical ripening compared with those who undergo hospital cervical ripening. However, preadmission home cervical ripening with 1 mg dinoprostone does not decrease the number of hours women spend in the hospital. II.

  • Home Cervical Ripening With Dinoprostone Gel in Nulliparous Women with Singleton Pregnancies
    Obstetrics & Gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Kirsty Dundas, Chris Kissack, Jane E Norman, Rebecca E. Taylor, Imogen B. J. Smith, Fiona C. Denison
    Abstract:

    OBJECTIVE:To evaluate whether home cervical ripening is safe and results in shorter hospital stay.METHODS:This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered hom

Kahyee Hor - One of the best experts on this subject based on the ideXlab platform.

  • PA.03 Outcomes of Outpatient Cervical Ripening with 1mg Dinoprostone Gel in Primiparous Singleton Pregnancy: A Cohort Study
    Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Chris Kissack, Jane E Norman, Imogen B. J. Smith, R A M Taylor, Kc Dundas, Fiona C. Denison
    Abstract:

    Aim To determine the safety and clinical effectiveness of outpatient cervical ripening with Dinoprostone 1 mg. Methods Retrospective cohort study of women with singleton pregnancies having induction of labour (IOL) for Postmaturity at the Royal Infirmary of Edinburgh between January 2007 and June 2010 (n = 1,536). Women were offered outpatient cervical ripening with 1mg Dinoprostone gel if they were primiparous; had uncomplicated singleton pregnancies; and the primary indication for IOL was Postmaturity (term +10 -14 days). Findings 907 (59.1%) women were eligible for outpatient cervical ripening and 85 (5.5%) women had inpatient cervical ripening only because of preference or social indication (comparison group; n = 85). 597/907 (65.8%) in outpatient cervical ripening group completed the protocol, with median number of hours at home of 11.76 h (range 0–24.82 h). No babies were born at home. Mode of delivery, requirement for further Dinoprostone, failed IOL and neonatal unit admission rates were similar in outpatient and inpatient cervical ripening groups. The mean time to delivery was significantly longer in the outpatient group (35.45 [95% confidence interval 34.36–36.53] in outpatient group versus 22.5 [95% confidence interval 21.06–23.95] in the inpatient group p Conclusion Clinical outcomes for outpatient cervical ripening are similar to those of inpatient ripening. Surprisingly, outpatient ripening did not decrease the number of hours women spend in hospital.

  • Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies.
    Obstetrics and gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Taylor, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Imogen Smith, Kirsty Dundas, Chris Kissack, Jane E Norman, Fiona Denison
    Abstract:

    To evaluate whether home cervical ripening is safe and results in shorter hospital stay. This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered home cervical ripening with 1 mg dinoprostone gel if they were nulliparous, had uncomplicated singleton pregnancies, and the indication for induction was Postmaturity. Nine hundred seven of 1,536 (59.1%) nulliparous women having induction of labor for Postmaturity were eligible for home cervical ripening. The median number of hours at home was 11.76 hours (range 0-24.82 hours). There were no cases of birth outside of the hospital, uterine rupture, or significant neonatal morbidity or neonatal death related to home cervical ripening. Eighty-five (5.5%) women who underwent hospital cervical ripening because of maternal preference or social issues formed a hospital cervical ripening comparison group. There was no significant difference in the total number of hours before delivery spent in the hospital between the two groups (26.25; 95% confidence interval [CI] 25.27-27.23 in home cervical ripening group compared with 24.28; 95% CI 22.5-26.0 in the hospital group; P=.26). Clinical outcomes are comparable in nulliparous women who receive a single dose of dinoprostone gel for home cervical ripening compared with those who undergo hospital cervical ripening. However, preadmission home cervical ripening with 1 mg dinoprostone does not decrease the number of hours women spend in the hospital. II.

  • Home Cervical Ripening With Dinoprostone Gel in Nulliparous Women with Singleton Pregnancies
    Obstetrics & Gynecology, 2014
    Co-Authors: Sarah J Stock, Rebecca Mairs, Abdulhamid Azaghdani, Kahyee Hor, Kirsty Dundas, Chris Kissack, Jane E Norman, Rebecca E. Taylor, Imogen B. J. Smith, Fiona C. Denison
    Abstract:

    OBJECTIVE:To evaluate whether home cervical ripening is safe and results in shorter hospital stay.METHODS:This was a retrospective cohort study of women with singleton pregnancies having induction of labor for Postmaturity at a single center between January 2007 and June 2010. Women were offered hom